Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-80
SponsorFudan University
About this trial
This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1012. The goal of this clinical trial is to confirm the theraputic effect of segmentectomy for ground glass-dominant invasive lung cancer with size of 2-3cm. The main questions it aims to answer are:
* The 5-year disease-free survival of patients having ground glass-dominant invasive lung cancer with size of 2-3cm; * The post-operative lung function tests after receiving segmentectomy. Participants will receive segmentectomy as the surgical procedure.
Eligibility criteria
Qualifiers
Patients who sign the informed consent form and are willing to complete the study according to the plan;
Aged from 18 to 80 years old;
ECOG equals 0 or 1;
Not receiving lung cancer surgery before;
Disqualifiers
CTR is not 0-0.5, or size is not 2-3cm;
Tumors could not be completely resected assed by surgeons;
Not lung adenocarcinoma diagnosed cytologically or pathologically;
Receiving lung cancer surgery before;
Trial design
Treatments tested in this trial
- Segmentectomy
Treatment groups
307 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov